Emergent Biosolutions, Inc.(NYSE: EBS) is on The StockGuru Leader Board today. The stock closed up 9.22% on Friday.
Volume was 434,417 shares traded.
Join in on the Discussion about EBS: http://members.stockguru.com/stocks/ebs/
About the Company:
Emergent BioSolutions Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of vaccines and antibody therapeutics primarily in the United States, the United Kingdom, and Vietnam. The company operates in two segments, BioDefense and BioSciences. The BioDefense segment offers vaccines and antibody therapies for use against biological agents that are potential weapons of bioterrorism or biowarfare focusing on anthrax. It manufactures and markets BioThrax, a vaccine for the prevention of anthrax infection. This segment also involves in developing PreviThrax, a recombinant protective antigen anthrax vaccine; Anthrivig, a human anthrax immunoglobulin; Thravixa, a fully human anthrax monoclonal antibody; NuThrax, an anthrax vaccine absorbed with CPG 7909 adjuvant; and a double mutant recombinant protective antigen anthrax vaccine. The BioSciences segment includes clinical and preclinical stage investigational product candidates. This segment provides MVA-85A, a prophylactic recombinant tuberculosis vaccine; Typhella, a prophylactic vaccine for the treatment of typhoid; multivalent, cross-protective pandemic influenza vaccine; pandemic H5 influenza MAb, a monoclonal antibody therapeutic; SBI-087 a therapeutic for the treatment of rheumatoid arthritis and Systemic lupus erythematosus; and TRU-016, a therapeutic used in the treatment of Chronic lymphocytic leukemia and non-Hodgkins lymphoma disease. It sells its products to healthcare providers and purchasers for use in preventing and treating disease in the biodefense and commercial markets. The company was founded in 1998 and is based in Rockville, Maryland.
About the StockGuru Leader Board:
We watch for stocks moving up and creating a positive momentum in the market. We are not compensated for coverage.
Feel free to suggest a stock for coverage if you see it breaking out. Contact: email@example.com.
All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: Publisher@StockGuru.com or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070